Journal
ACTA NEUROPATHOLOGICA COMMUNICATIONS
Volume 7, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s40478-019-0840-1
Keywords
alpha-Synuclein; Luminescent conjugated oligothiophene; Multiple system atrophy; Neurodegeneration; Parkinson's disease; Spectral analysis
Categories
Funding
- Fondation pour la Recherche sur Alzheimer
- U.K. Medical Research Council [MC_U105184291]
- Swedish Research Council [2016-00748]
- NIA [PHS P30 AG010133]
- Multiple System Atrophy Trust
- Multiple System Atrophy Coalition
- Fund Sophia
- CBD Solutions
- Reta Lila Weston Institute for Neurological Studies
- U.K. Medical Research Council
- MRC [MC_U105184291] Funding Source: UKRI
Ask authors/readers for more resources
Synucleinopathies [Parkinson's disease with or without dementia, dementia with Lewy bodies and multiple system atrophy] are neurodegenerative diseases that are defined by the presence of filamentous alpha-synuclein inclusions. We investigated the ability of luminescent conjugated oligothiophenes to stain the inclusions of Parkinson's disease and multiple system atrophy. They stained the Lewy pathology of Parkinson's disease and the glial cytoplasmic inclusions of multiple system atrophy. Spectral analysis of HS-68-stained inclusions showed a red shift in multiple system atrophy, but the difference with Parkinson's disease was not significant. However, when inclusions were double-labelled for HS-68 and an antibody specific for alpha-synuclein phosphorylated at S129, they could be distinguished based on colour shifts with blue designated for Parkinson's disease and red for multiple system atrophy. The inclusions of Parkinson's disease and multiple system atrophy could also be distinguished using fluorescence lifetime imaging. These findings are consistent with the presence of distinct conformers of assembled a-synuclein in Parkinson's disease and multiple system atrophy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available